LV10974A - Panemiens jaunu plazmidu iegusanai un to pielietojums plazminogena aktivatora iegusanai (Jauni polipeptidi kodejosas plazmidas to iegusanas panemiens un pielietojums) - Google Patents
Panemiens jaunu plazmidu iegusanai un to pielietojums plazminogena aktivatora iegusanai (Jauni polipeptidi kodejosas plazmidas to iegusanas panemiens un pielietojums)Info
- Publication number
- LV10974A LV10974A LV931312A LV931312A LV10974A LV 10974 A LV10974 A LV 10974A LV 931312 A LV931312 A LV 931312A LV 931312 A LV931312 A LV 931312A LV 10974 A LV10974 A LV 10974A
- Authority
- LV
- Latvia
- Prior art keywords
- application
- plasminogen activator
- codose
- attempt
- plasmids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3153—Streptokinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4101736A DE4101736A1 (de) | 1991-01-22 | 1991-01-22 | Neue als plasminogenaktivatoren einsetzbare polypeptide, dafuer codierende plasmide und verfahren zu deren herstellung und deren verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
LV10974A true LV10974A (lv) | 1995-12-20 |
Family
ID=6423453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LV931312A LV10974A (lv) | 1991-01-22 | 1993-12-08 | Panemiens jaunu plazmidu iegusanai un to pielietojums plazminogena aktivatora iegusanai (Jauni polipeptidi kodejosas plazmidas to iegusanas panemiens un pielietojums) |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0496327B1 (lv) |
JP (1) | JPH06169770A (lv) |
AT (1) | ATE204326T1 (lv) |
DE (2) | DE4101736A1 (lv) |
DK (1) | DK0496327T3 (lv) |
ES (1) | ES2164048T3 (lv) |
FI (1) | FI920263A (lv) |
HK (1) | HK1010108A1 (lv) |
HU (1) | HU212510B (lv) |
IE (1) | IE914040A1 (lv) |
IL (1) | IL100163A0 (lv) |
LT (1) | LT3948B (lv) |
LV (1) | LV10974A (lv) |
PT (1) | PT496327E (lv) |
RU (1) | RU2108387C1 (lv) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780303A (en) * | 1990-04-06 | 1998-07-14 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US6017877A (en) * | 1990-04-06 | 2000-01-25 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US5672585A (en) * | 1990-04-06 | 1997-09-30 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US6521594B1 (en) | 1990-04-06 | 2003-02-18 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
KR100225511B1 (ko) * | 1994-12-30 | 1999-10-15 | 성재갑 | 소 성장호르몬의 대량 생산 방법 |
JP2003521222A (ja) * | 1998-03-06 | 2003-07-15 | アボット・ラボラトリーズ | 高度結晶性ウロキナーゼ |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL68366A (en) * | 1982-04-15 | 1990-08-31 | Genentech Inc | Process for expressing a gene encoding a protein comprising the enzymatic portion of human urokinase in a microorganism or cell culture |
NL8601240A (nl) | 1986-05-15 | 1987-12-01 | Leuven Res & Dev Vzw | Plasminogeenactivator en trombolytisch geneesmiddel. |
EP0316068A1 (en) * | 1987-10-09 | 1989-05-17 | Collaborative Research Inc. | Modified low molecular weight plasminogen activator and method of preparation |
DE3735917A1 (de) * | 1987-10-23 | 1989-05-03 | Basf Ag | Neue polypeptide, ihre herstellung und verwendung |
DE3810474A1 (de) * | 1988-03-26 | 1989-10-05 | Boehringer Ingelheim Int | Expressionsvektoren |
GB8809093D0 (en) * | 1988-04-18 | 1988-05-18 | Erba Carlo Spa | Low molecular weight derivatives of prourokinase |
AU5515790A (en) * | 1989-05-18 | 1990-11-22 | Green Cross Corporation, The | Human prourokinase variants, methods of producing same, dna sequences, plasmids and hosts therefor |
IE901849A1 (en) * | 1989-07-19 | 1991-06-19 | Gruenenthal Gmbh | Plasmids, their preparation and their use in the manufacture¹of a plasminogen activator |
-
1991
- 1991-01-22 DE DE4101736A patent/DE4101736A1/de not_active Withdrawn
- 1991-11-20 IE IE404091A patent/IE914040A1/en not_active Application Discontinuation
- 1991-11-27 IL IL100163A patent/IL100163A0/xx unknown
-
1992
- 1992-01-09 RU SU5010518A patent/RU2108387C1/ru active
- 1992-01-15 HU HU9200127A patent/HU212510B/hu not_active IP Right Cessation
- 1992-01-20 ES ES92100864T patent/ES2164048T3/es not_active Expired - Lifetime
- 1992-01-20 PT PT92100864T patent/PT496327E/pt unknown
- 1992-01-20 EP EP92100864A patent/EP0496327B1/de not_active Expired - Lifetime
- 1992-01-20 AT AT92100864T patent/ATE204326T1/de not_active IP Right Cessation
- 1992-01-20 DE DE59209915T patent/DE59209915D1/de not_active Expired - Fee Related
- 1992-01-20 DK DK92100864T patent/DK0496327T3/da active
- 1992-01-21 JP JP4008765A patent/JPH06169770A/ja active Pending
- 1992-01-21 FI FI920263A patent/FI920263A/fi unknown
-
1993
- 1993-12-06 LT LTIP1532A patent/LT3948B/lt not_active IP Right Cessation
- 1993-12-08 LV LV931312A patent/LV10974A/lv unknown
-
1998
- 1998-09-25 HK HK98110955A patent/HK1010108A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK0496327T3 (da) | 2001-12-03 |
ATE204326T1 (de) | 2001-09-15 |
EP0496327A1 (de) | 1992-07-29 |
FI920263A (fi) | 1992-07-23 |
EP0496327B1 (de) | 2001-08-16 |
FI920263A0 (fi) | 1992-01-21 |
DE59209915D1 (de) | 2001-09-20 |
LTIP1532A (en) | 1995-06-26 |
HUT63877A (en) | 1993-10-28 |
LT3948B (en) | 1996-05-27 |
HU212510B (en) | 1996-07-29 |
DE4101736A1 (de) | 1992-07-23 |
PT496327E (pt) | 2002-02-28 |
IL100163A0 (en) | 1992-08-18 |
HK1010108A1 (en) | 1999-06-11 |
ES2164048T3 (es) | 2002-02-16 |
JPH06169770A (ja) | 1994-06-21 |
RU2108387C1 (ru) | 1998-04-10 |
IE914040A1 (en) | 1992-07-29 |
HU9200127D0 (en) | 1992-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8801674A1 (es) | Un procedimiento para la preparacion de una proteina que presenta actividad procoagulante. | |
IT1153265B (it) | Polipeptidi contenenti la sequenza degli amminoacidi dell'interferone umano immune (interferone umano gamma), relativi veicoli di espressione, loro procedimento di preparazione, composizioni farmaceutiche contenenti tali polipeptidi | |
DE3871798D1 (de) | Modifizierter faktor vii/viia. | |
IL85020A (en) | Pancreatic secretory trypsin inhibitor variants, their production, expression vectors and recombinant hosts therefor and pharmaceutical compositions containing them | |
NO882763D0 (no) | Humant apolipoprotein ai og variantform av samme uttrykt i escherichia coli. | |
EP0030920A3 (en) | Acyl peptides and pharmaceutical preparations thereof, as well as their manufacture and use | |
DE3584579D1 (de) | Herstellung von polypeptiden mit human-gammainterferon-aktivitaet. | |
FI99116B (fi) | Menetelmä valmistaa hevosen -interferonia | |
LV10974A (lv) | Panemiens jaunu plazmidu iegusanai un to pielietojums plazminogena aktivatora iegusanai (Jauni polipeptidi kodejosas plazmidas to iegusanas panemiens un pielietojums) | |
DE3462039D1 (en) | Peptide derivatives, their preparation and use as elastase inhibitors | |
YU46814B (sh) | Fuzioni polipeptid koji sadrži dvojne jedinice ponavljanja cirkumsporozoitnog (cs) proteina plasmodium falciparum | |
AR013618A1 (es) | Metodo y composiciones para la distribucion y expresion de acidos nucleicos de interferon | |
Woolley et al. | High strepogenin potency of synthetic oxytocin and of purified vasopressin | |
GB8906156D0 (en) | Production and use of anthelmintic agents and protective immunogens | |
SE7712634L (sv) | Ny polypeptid med serumkalciumreducerande aktivitet | |
AU575331B2 (en) | Improved e. coli plasmid containing modified 5' cipoprotein sequence | |
GB1437477A (en) | Synthetic peptides | |
EP0238275A3 (en) | Recombinant product | |
GB1357122A (en) | Polypeptide intermediates | |
Yamada et al. | Dramatic Differences in the Effectiveness among Various Coupling Methods in the Synthesis of Peptides Containing. ALPHA.,. ALPHA.-Diphenylglycine. | |
IT1186750B (it) | Vettore di clonaggio,molecole di dna ricombinante,ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni | |
ATE147268T1 (de) | Hypoglycemische peptide | |
DE69121227D1 (de) | Polypeptid | |
IT8249433A0 (it) | Procedimento per la produzione di un polipeptide eterologo mediante espressione di un vettore di clonazione ricombinante, vettore impiegato e microrganismo ospite cosi' trasformato | |
DK200200302A (da) | Rekombinante polypeptider omfattende aminosyresekvensen af moden vævsfaktorinhibitor (TFI), polypeptidfragmenter deraf, ekspressionsvektorer der koder for disse, værtsceller transformeret dermed, og fremgangsmåde til fremstilling af et ........ |